GlassScriptPhysician profile
Oksana Senyk
NPI 1306866868
$533.49
in general payments reported to CMS, 2019-2025
10 companies · $38.94 in 2025
The $38.94 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.62 · 2021: $95.33 · 2022: $105 · 2023: $159 · 2024: $100 · 2025: $38.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $187.49 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $93.99 | 2019-2025 | Nucala |
| Mylan Specialty L.P. | $56.45 | 2021-2023 | Yupelri |
| Genzyme Corporation | $34.96 | 2024 | |
| Pulmonx Corporation | $34.73 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.64 | 2024 | Stiolto Respimat, Spiriva Respimat |
| Philips North America LLC | $28.66 | 2022-2024 | (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $27.70 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.99 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.88 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oksana Senyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.